In 2024, Oz Medicann Group (OMG) plans to conduct three medical trials in collaboration with NICM Health Research Institute and New Zealand Medical Research Institute to test the efficacy of CBD medications for sleep, anxiety, and pain. Led by Alan Bensoussan, the trials aim to develop innovative cannabinoid remedies and address unmet medical needs.
Read the full story here
Written by: Steve Jones
Published on February 13, 2024 at 06:11PM
Source: Cannabiz (opens in new tab)